Matt Hewitt
Stock Analyst at Craig-Hallum
(2.67)
# 1,892
Out of 5,172 analysts
43
Total ratings
54.05%
Success rate
2.59%
Average return
Main Sectors:
Stocks Rated by Matt Hewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLP Simulations Plus | Maintains: Buy | $45 → $36 | $11.67 | +208.48% | 8 | Jun 13, 2025 | |
| CSBR Champions Oncology | Maintains: Buy | $8 → $12 | $5.86 | +104.78% | 4 | Mar 12, 2025 | |
| CLOV Clover Health Investments | Initiates: Buy | $6 | $1.89 | +217.46% | 1 | Dec 17, 2024 | |
| BLFS BioLife Solutions | Maintains: Buy | $30 → $32 | $18.85 | +69.76% | 4 | Nov 13, 2024 | |
| OMCL Omnicell | Maintains: Buy | $45 → $64 | $33.09 | +93.41% | 6 | Oct 31, 2024 | |
| LGND Ligand Pharmaceuticals | Maintains: Buy | $135 → $140 | $204.81 | -31.64% | 3 | Jul 9, 2024 | |
| NOTV Inotiv | Maintains: Buy | $25 → $10 | $0.30 | +3,271.54% | 3 | May 16, 2024 | |
| SDGR Schrödinger | Maintains: Buy | $35 → $30 | $12.02 | +149.58% | 3 | May 2, 2024 | |
| MXCT MaxCyte | Initiates: Buy | $7 | $0.77 | +814.79% | 1 | Nov 29, 2023 | |
| RGEN Repligen | Maintains: Buy | $207 → $200 | $113.88 | +75.62% | 3 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.75 | +471.43% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $67 → $30 | $5.35 | +460.75% | 5 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $400 | $0.20 | +203,981.63% | 1 | Jan 4, 2022 |
Simulations Plus
Jun 13, 2025
Maintains: Buy
Price Target: $45 → $36
Current: $11.67
Upside: +208.48%
Champions Oncology
Mar 12, 2025
Maintains: Buy
Price Target: $8 → $12
Current: $5.86
Upside: +104.78%
Clover Health Investments
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $1.89
Upside: +217.46%
BioLife Solutions
Nov 13, 2024
Maintains: Buy
Price Target: $30 → $32
Current: $18.85
Upside: +69.76%
Omnicell
Oct 31, 2024
Maintains: Buy
Price Target: $45 → $64
Current: $33.09
Upside: +93.41%
Ligand Pharmaceuticals
Jul 9, 2024
Maintains: Buy
Price Target: $135 → $140
Current: $204.81
Upside: -31.64%
Inotiv
May 16, 2024
Maintains: Buy
Price Target: $25 → $10
Current: $0.30
Upside: +3,271.54%
Schrödinger
May 2, 2024
Maintains: Buy
Price Target: $35 → $30
Current: $12.02
Upside: +149.58%
MaxCyte
Nov 29, 2023
Initiates: Buy
Price Target: $7
Current: $0.77
Upside: +814.79%
Repligen
Aug 3, 2023
Maintains: Buy
Price Target: $207 → $200
Current: $113.88
Upside: +75.62%
Apr 13, 2023
Initiates: Buy
Price Target: $10
Current: $1.75
Upside: +471.43%
Apr 28, 2022
Maintains: Hold
Price Target: $67 → $30
Current: $5.35
Upside: +460.75%
Jan 4, 2022
Initiates: Buy
Price Target: $400
Current: $0.20
Upside: +203,981.63%